AMPK activity is enhanced in quiescent ovarian cancer spheroids, and in a reciprocal fashion, pharmacologic activation of AMPK in proliferating, adherent ovarian cancer cells leads to cytostasis. Here, PRKAA2 is linked to ovarian cancer.